✦ LIBER ✦

Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors

✍ Scribed by Tomicic, Maja T.; Kaina, Bernd

Book ID: 120268657
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 802 KB
Volume: 1835
Category: Article
ISSN: 0304-419X
DOI: 10.1016/j.bbcan.2012.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

117 Characterization of high and low lev

117 Characterization of high and low level resistance to topoisomerase I poisons in small cell lung cancer cells resistant to camptothecin and topotecan

✍ Sorensen, M.; Sehested, M.; Christensen, I.J.; Jensen, P.B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Evaluation of novel platinum complexes,

Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

BCRP/ABCG2 levels account for the resist

BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer

✍ Seiji Nagashima; Hiroshi Soda; Mikio Oka; Takeshi Kitazaki; Ken Shiozawa; Yoichi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 304 KB

Apoptotic response to camptothecin and 7

Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase i, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways

✍ Wilberto Nieves-Neira; Yves Pommier 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 2 views

Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce